OpenBilldrug price receipt

NADAC week of 2026-10-14

NICARDIPINE 20 MG CAPSULE

For 30 capsules

Pharmacies pay

$33.60 filed

30 × $1.12012 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$131.19 filed

30 × $4.37308 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

The spread

3.9× estimated

Medicare paid 3.9× what pharmacies pay.

Part D averages every strength and form sold under “Nicardipine HCl*” / “Nicardipine HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$43.64 estimated

$33.60 + $5.04 (15%) + $5.00 fee per fill = $43.64

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

NICARDIPINE 20 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “nicardipine” and “nicardipine hydrochloride”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as capsule and its route as oral.

FDA lists 6 labelers (the companies named on the label) for its NDCs, among them Epic Pharma, LLC, ANI Pharmaceuticals, Inc. and Glenmark Pharmaceuticals Inc., USA.

FDA’s Established Pharmacologic Class for it is Dihydropyridine Calcium Channel Blocker.

The NADAC file of 2026-10-14 prices it under 6 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $33.60 for 30 capsules (30 × $1.12012 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

What NADAC measures · Why 30 capsules · NADAC explanation codes

All 6 NDCs

Compared with its class

The middle of its 6 NDCs’ NADAC prices is $1.12012 per EA filed.

Of the 67 other products in FDA’s Dihydropyridine Calcium Channel Blocker class priced per EA, 34 have a higher middle NADAC price and 33 a lower one. The one in the middle is ISRADIPINE 2.5 MG CAPSULE, at $1.13676 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $131.19 for 30 capsules, at an average of $4.37308 per EA in 2024 (2024-01-01 to 2024-12-31) for “Nicardipine HCl*” and “Nicardipine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 4,030 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for NICARDIPINE 20 MG CAPSULE labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Nicardipine HCl* / Nicardipine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. All 6 NADAC NDCs the name join matched to it have an FDA route including ORAL.

Its pharmacologic class

Related in the same class

More